PPCB · Propanc Biopharma, Inc.
$1.21
-0.11 (-8.33%)
At close · Jul 28
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“It is management's opinion that these conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of at least twelve months from the issue date of this Quarterly Report.”View the 10-Q filed May 14, 2026
Market Cap
$68.92M
Shares
56.96M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-29 | 6,101 | $1.47 | $8,968 |
| 2026-06-25 | 10,050 | $1.49 | $14,975 |
| 2026-06-24 | 2,813 | $1.47 | $4,135 |
| 2026-06-18 | 5,110 | $1.71 | $8,738 |
| 2026-06-17 | 6,214 | $1.93 | $11,993 |
| 2026-06-16 | 43,265 | $2.15 | $93,020 |
| 2026-06-15 | 186,969 | $2.27 | $424,420 |
| 2026-06-12 | 607,995 | $2.43 | $1,477,428 |
| 2026-06-08 | 181 | $1.45 | $262 |
| 2026-06-04 | 323 | $1.63 | $526 |
| 2026-06-03 | 1,131 | $1.77 | $2,002 |
| 2026-06-02 | 1 | $1.81 | $2 |
| 2026-06-01 | 1,212 | $1.82 | $2,206 |
| 2026-05-29 | 1 | $1.70 | $2 |
| 2026-05-28 | 1,233 | $1.62 | $1,997 |
| 2026-05-27 | 1,043 | $1.74 | $1,815 |
| 2026-05-22 | 111 | $1.73 | $192 |
| 2026-05-21 | 2 | $1.76 | $4 |
| 2026-05-20 | 11,484 | $2.01 | $23,083 |
| 2026-05-19 | 10,445 | $2.01 | $20,994 |
| 2026-05-13 | 54,781 | $0.09 | $4,930 |
| 2026-05-12 | 84,628 | $0.09 | $7,617 |
| 2026-05-07 | 814 | $0.10 | $81 |
| 2026-04-29 | 97 | $0.11 | $11 |
Showing 1–24 of 24 settlements